AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) — Phoenix, Arizona

AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) is a clinical research site located in Phoenix, Arizona, United States 85035.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) has participated in 1 clinical trials.

Therapeutic areas: End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Phoenix

Browse all research sites in Arizona · View every site in Phoenix

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723)?

AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) conducted?

AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) has 1 clinical trials on record. Their work covers End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic.

Is AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) accredited by Crixeo Clinical Trials?

AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AKDHC MEDICAL RESEARCH SERVICES, LLC-Maryvale ( Site 0723)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.